[ Price : $8.95]
Federal Register notice: FDA determines that Boehringer Ingelheim Pharmaceuticals Atrovent (ipratropium bromide) metered spray 0.0...[ Price : $8.95]
FDA grants accelerated approval for Biogens Aduhelm (aducanumab), the first drug since 2003 approved for treating Alzheimers.[ Price : $8.95]
FDA approves a Medtronic PMA for the SenSight Directional Lead System used for deep brain stimulation therapy.[ Price : $8.95]
FDA approves an Alexion Pharmaceuticals BLA for Ultomiris (ravulizumab-cwvz) injection and its use in treating patients aged one m...[ Price : $8.95]
FDA lifts clinical holds against Bluebird Bios Phase 1/2 (HGB-206) and Phase 3 (HGB-210) studies of LentiGlobin gene therapy for s...[ Price : $8.95]
FDA approves a ProMetic Biotherapeutics BLA for Ryplazim (plasminogen, human-tmvh) for treating patients with plasminogen deficien...[ Price : $8.95]
Federal Register notice: FDA posts a draft guidance on drug supply chain definitions of suspect and illegitimate products.[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Product Identifiers Under the Drug Supply Chain Security Ac...